Nueva publicación en la revista Retina Today
El Prof. Dr. Marcelo Zas publicó un nuevo trabajo en la prestigiosa revista científica Retina Today, llamado "When to Use Steroids for Retinal Vein Occlusion - Early, late, or never?"
Adelanto (en inglés)
Retinal vein occlusion (RVO) is the second most common retinal vascular disorder after diabetic retinopathy (DR).1-5 It can result in vision impairment or blindness if left untreated. Estimates are that 16 million people worldwide are affected by RVO in one or both eyes, and the incidence of RVO is approximately 520 new cases per 1 million annually.1-5 The risk of RVO markedly increases with age, with the disease typically occurring in patients older than 50 years.
This article reviews current treatment strategies for RVO with steroids, the mechanisms of action of these drugs, and the rationale for their use in the two major entities of RVO presentation: branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRVO).
Por favor ingrese en este enlace.